G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/26/2002	US6485686 Method and apparatus for counting submicron sized particles
11/26/2002	US6484652 Soil constituent sensor and precision agrichemical delivery system and method
11/26/2002	US6484595 Device for determining the disintegration time of compressed pharmaceutical mold bodies, such as tablets and capsules, as well as a method for this purpose
11/26/2002	US6484563 Method at detection of presence of hydrogen gas and measurement of content of hydrogen gas
11/26/2002	US6484557 Slide-typed switch durability testing apparatus for automobile
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2060330C Compositions and method for soft tissue tumors
11/26/2002	CA2026639C Management of infertility
11/26/2002	CA1341402C Chemiluminescent acridine derivatives and their use in luminescence immunoassays
11/25/2002	WO2001098778A1 Breath-alcohol measuring instrument
11/25/2002	CA2387332A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
11/25/2002	CA2387287A1 Methods for automatically monitoring analyte concentration using minimally invasive devices
11/25/2002	CA2387277A1 Information processing system using nucleotide sequence-related information
11/22/2002	WO2001090753A1 Analyzing device
11/22/2002	WO2001089383A2 System for removing body fluid, especially blood
11/21/2002	WO2002093454A1 System, method and computer readable medium for analysis of clusters of gene expression data
11/21/2002	WO2002093452A1 Method for identifying compounds in complex chemical mixtures
11/21/2002	WO2002093318A2 Systems and methods for monitoring behavior informatics
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002093176A2 Methods for identifying compounds for treatment of ibd
11/21/2002	WO2002093175A1 Methods and kits for the in vitro diagnostic or for the monitoring of a disease involving an inflammatory reaction
11/21/2002	WO2002093174A2 A method of treatment of alzheimer's disease and device therefor
11/21/2002	WO2002093172A1 Antigen binding fragments for dendritic cell subset and use thereof
11/21/2002	WO2002093171A2 Method for predicting the risk of transplant rejection and immunological testkit
11/21/2002	WO2002093169A1 Assay test system for regulating temperature
11/21/2002	WO2002093168A1 Prion diagnostic test
11/21/2002	WO2002093167A1 Body fluid inspection apparatus
11/21/2002	WO2002093166A1 Method for qualitative and/or quantitative determination of gender, species, race and/or geographical origin of biological materials
11/21/2002	WO2002093162A2 Individualization of therapy with antibiotic agents
11/21/2002	WO2002093161A1 Screening method
11/21/2002	WO2002093160A1 Method of detecting poisoning of a mos gas sensor
11/21/2002	WO2002093152A1 Method for the determination of glycated hemoglobin
11/21/2002	WO2002093150A1 Capacitive fuel sensor
11/21/2002	WO2002093147A1 Method and apparatus for defining water content of a liquid.
11/21/2002	WO2002093140A1 Multifunctional magnetic nanowires
11/21/2002	WO2002093134A1 Method for determining the presence of infection in an individual
11/21/2002	WO2002093131A2 Methods for isolating and labeling sample molecules
11/21/2002	WO2002093129A2 Methods for analyzing interactions between proteins in live and intact cells
11/21/2002	WO2002093128A2 Identifying insulin response modulators and therapeutic uses thereof
11/21/2002	WO2002093126A2 Method and apparatus for downhole fluid characterization using flxural mechanical resonators
11/21/2002	WO2002093125A2 Micromagnetic systems and methods for microfluidics
11/21/2002	WO2002093124A2 Markers for evaluating estrogenic activity
11/21/2002	WO2002092858A2 Methods of screening for disease
11/21/2002	WO2002092854A2 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	WO2002092849A2 Methods
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092837A2 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
11/21/2002	WO2002092834A2 High capacity assay platforms
11/21/2002	WO2002092833A2 Arrays of biological membranes and methods and use thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092813A1 Biomolecular substrate and method and apparatus for examination and diagnosis using the same
11/21/2002	WO2002092810A1 Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity
11/21/2002	WO2002092791A1 Tissues or organs for use in xenotransplantation
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092787A2 Human secreted proteins
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092776A2 Methods for the indentification of inhibitors of 2-hydroxyisoflavone reductase expression or activity in plants
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092768A2 Novel alanine transaminase enzyme and methods of use
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092763A2 Intron associated with myotonic dystrophy type 2 and methods of use
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092761A2 Screening assays for agonists or antagonists of cd40 signaling
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092732A2 Lubricant composition and analysis method for same
11/21/2002	WO2002092635A2 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
11/21/2002	WO2002092633A1 Method for extracting gluten contained in heat-processed and non-heat-processed foodstuffs, compatible with an enzyme-linked immunosorbent assay, composition and kits comprising said composition
11/21/2002	WO2002092631A1 Kinetic assay
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092615A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	WO2002092218A2 Surf2lead
11/21/2002	WO2002092200A1 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
11/21/2002	WO2002092199A1 Detection of cells using molecular electrophoretic change
11/21/2002	WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	WO2002092135A1 Methods of using labelled verotoxin b subunit
11/21/2002	WO2002092124A1 Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
11/21/2002	WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002092108A1 Methods for assessing antiangiogenic agents
11/21/2002	WO2002092101A1 Systems and methods for monitoring behavior informatics
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092007A2 Screening methods for pathogen virulence factors under low oxygen conditions.
11/21/2002	WO2002092002A2 Screening, diagnostic and therapeutic methods relating to riz
11/21/2002	WO2002092001A2 Compositions and methods for the therapy and diagnosis of lung cancer
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091921A1 Method and measuring equipment for measuring nitric oxide concentration in exhaled air
11/21/2002	WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002	WO2002081752A3 Methods and kits useful for the simplification of complex peptide mixtures
11/21/2002	WO2002080763A3 Blood testing device
11/21/2002	WO2002079783A3 Method and device for testing for bence-jones protein
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002076377A3 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody
11/21/2002	WO2002075289A3 Method and apparatus for improving the accuracy of noninvasive hematocrit measurements

1 ... 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 ... 3937